NSCLC Clinical Trials in Guangzhou, Guangdong
5 recruitingGuangzhou, Guangdong, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Non-small Cell Lung CancerNSCLC
Merck Sharp & Dohme LLC851 enrolled204 locationsNCT06422143
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 2
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
NSCLCEGFRAdjuvant Drug Therapy
Betta Pharmaceuticals Co., Ltd.28 enrolled2 locationsNCT07181499
Recruiting
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
Lung CancerCancerNSCLC+1 more
The First Affiliated Hospital of Guangzhou Medical University2,500 enrolled1 locationNCT06778512
Recruiting
Not Applicable
Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer
NSCLC
Energenx Medical LTD.10 enrolled1 locationNCT05987345